Insights for Connected, AI-Actionable Life Sciences
Explore the latest ideas shaping life sciences, with expert perspectives on agentic AI, operating system, architecture, contextualized data, and connected operations.
The AI-Ready Lab: Eliminating App-Hopping in Scientific Workflows
Agentic AI is already cutting app-hopping across HR, IT, and procurement, yet R&D and CMC teams still juggle disconnected LIMS, ELN, and MES systems. In this POV, L7 Founder and CEO Vasu Rangadass, Ph.D., explains how L7|ESP, the agentic operating system for precision science, unifies lab data to make it AI-actionable.
Blog Posts.
Building the Digital Backbone for Scalable Cell Therapies: Key Insights from Cell and Gene on the Mesa 2025
This panel discussion from Cell and Gene Meeting on the Mesa 2025 brings together leaders from Dana-Farber Cancer Institute, CTMC, Cellipont Bioservices, and L7 Informatics to explore the digital backbone required to scale cell therapy manufacturing. The conversation highlights why cell therapy demands new thinking, how fragmented systems create operational strain, and why real-time digital…
Every Technology Wave Needs Its Infrastructure: Why AI in Life Sciences is No Different
AI adoption is accelerating in life sciences, but most organizations lack the infrastructure needed to scale it. Drawing on Gartner, Deloitte, and McKinsey insights, this article explains why AI requires unified data, standardized workflows, and contextualized outputs. L7|ESP® provides the digital backbone that enables AI readiness across the value chain.
The Best Way to Achieve AI-Readiness for Life Sciences
Gartner’s latest insights reveal that while AI is ready, most enterprises lack the data foundation to support it. In life sciences, disconnected systems and poor data context limit AI’s impact. This article explores why a unified digital backbone is essential for achieving true AI-readiness.
The Ontology Advantage: Enabling Smarter, Connected Decisions in Life Sciences with L7|ESP®
Life sciences organizations face exponential data growth across research, development, and manufacturing. L7|ESP delivers an ontology-driven platform that unifies fragmented data into a self-learning digital twin—contextualizing information, enabling decision intelligence, and creating continuous feedback loops. Like Palantir transformed defense and finance, L7|ESP brings integrated, actionable intelligence to life sciences organizations.
Closing the Digital Maturity Gap
Marcia Blackmoore explores the widening digital maturity gap in CDMOs and how digital unified platforms address compliance, scalability, and sponsor trust. Featuring insights from Cellipont BioServices and a Contract Pharma webinar, this article shows why digital maturity is now essential for accelerating therapies to patients.
Today’s Best ELN May Not Be Another ELN
Swapping one ELN for another won’t fix silos or deliver sustainable ROI. In this POV, Vasu Rangadass, Ph.D., explains why life sciences companies must stop the cycle of point-solution replacements and embrace a digital unified platform that contextualizes data, orchestrates workflows, and prepares R&D and manufacturing for AI.
Decoding the Platform Hype: A Modern Buyer’s Guide to Digital Life Sciences Platforms
This buyer’s guide to digital life sciences platforms helps organizations cut through vendor hype. Learn how to evaluate claims of “platforms,” compare leading solutions, and identify the features that matter (AI readiness, orchestration, compliance, and contextualized data) so your next investment scales research, manufacturing, and innovation.
Architecture is the Moat: The Hidden Source of AI Advantage in Life Sciences
Life sciences companies are investing heavily in AI, but true advantage doesn’t come from data or algorithms. It comes from architecture; the orchestrated backbone that transforms data into compounding value. This piece explores why architecture is hard to copy and why it’s essential for digital twins, adaptive trials, and personalized medicine.
The Rise of AI Corporate Citizens: Why Life Sciences Organizations Need Data Orchestration, Not Just More Software
AI isn’t a sidekick anymore, it’s like a colleague. But in life sciences, fragmented data often prevents AI from delivering real value. This blog explores how data orchestration enables autonomous agents to thrive as AI corporate citizens, helping organizations move from experimental AI to production-ready, outcome-driven transformation.
Turning Data Into an Engine for Innovation: Why Contextualization and Orchestration Matter More Than Ever in Life Sciences
Life sciences organizations generate vast amounts of data, but 57% report it's not AI-ready due to fragmentation and missing context. Leading companies are achieving measurable ROI by implementing orchestrated, contextualized data platforms that connect every point where data is produced and used.
Top 5 Considerations for Lab Digital Transformation: What Gartner’s Market Convergence Means for Your Data Migration Strategy
Life sciences organizations face complex data migration challenges when modernizing laboratory systems. This article outlines five strategic considerations for digital transformation: platform composability, cross-system orchestration, AI-ready architecture, regulatory compliance, and total cost optimization. Learn how unified platforms enable successful migration from fragmented legacy systems to converged digital operations.
Top 5 Hidden Costs of Delaying Digital Transformation in Life Sciences
Delaying digital transformation comes at a high price for life sciences organizations. This article reveals the top five hidden costs, from lost productivity and rising expenses to missed AI opportunities, compliance risks, and talent drain, supported by leading research. Find out why now is the time to act for a digital future.